Analyst Peter Verdult works at CITI and is covering the the Healthcare sector with 33 price targets and ratings documented since 2016 spanning on 4 stocks.
Peter Verdult's average stock forecast success ratio is 37.5% with an average time for price targets to be met of 59.75 days.
Most recent stock forecast was given on EVO, at 11-Nov-2022.
Analyst best performing recommendations are on NVO.
The best stock recommendation documented was for NVO at 3/2/2022. The price target of $119.36 was fulfilled within 36 days with a profit of $15.96 (15.44%) receiving and performance score of 4.29.
Average potential price target upside
Currently, out of the existing stock ratings of Peter Verdult - 4 which are a Hold (57.14%), 3 which are a Buy (42.86%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
45
$2.25 (5.26%)
42
8 days ago
5/7 (71.43%)
$8.51 (12.74%)
81
Hold
69
$26.25 (61.40%)
1 months ago
3/5 (60%)
$27 (35.75%)
138
Hold
41
$-1.75 (-4.09%)
43
1 months ago
12/14 (85.71%)
$-3.94 (3.23%)
44
Hold
44
$1.25 (2.92%)
57
3 months 12 days ago
13/29 (44.83%)
$22.02 (27.13%)
167
Sell
47.2
$4.45 (10.41%)
158
4 months 16 days ago
1/4 (25%)
$11.21 (7.56%)
234
